Medtronic has announced new insulin delivery systems built around continuous monitoring and automation, aiming to ease daily management and improve quality of life for people with diabetes amid a shift towards smarter, integrated care solutions.
Medtronic is promoting a new push to give people with diabetes more time and less day-to-day burden, as the company unveils two systems built around continuous monitoring and automation. In Milan, the company said the MiniMed 780G with the new Instinct sensor and the MiniMed Go with Instinct Go are designed to make glucose management simpler, more integrated and less intrusive in everyday life.
The announcement reflects a broader shift in diabetes care towards continuous glucose monitors, or CGMs, and automated insulin delivery systems. Medtronic says CGMs track glucose every few minutes through a sensor under the skin, while automated insulin delivery combines a monitor, an insulin pump and a smart algorithm so the devices can adjust insulin in response to changing readings. In practical terms, that means fewer manual decisions and more real-time support.
Luigi Morgese, senior business leader at Medtronic Diabetes, said the aim of current technology in type 1 diabetes is to return time to patients, adding that more automated solutions should translate into a better life for people living with the condition. Riccardo Candido, president of Fondazione AMD, said sensor-based monitoring and automated insulin infusion are important not only for glucose control and complication prevention, but also for freedom and autonomy in daily activities.
The company is also expanding beyond pump-based treatment. In January, Medtronic said the MiniMed Go smart multiple daily injection system had won US Food and Drug Administration clearance and would pair the InPen smart insulin pen with the Instinct sensor in a single app. The move suggests Medtronic is trying to serve both pump users and people who rely on injections, while keeping the same emphasis on data integration and easier management.
Matteo Parenzan, a Paralympic champion, said the technology helps him manage diabetes with less anxiety and fewer pressures, because continuous monitoring reduces the number of decisions he has to make each day. Salvatore De Cosmo, president of AMD, said the doctor-patient relationship remains essential, even as technology adds more data and information to personalise care. For Medtronic, the message is clear: the value of innovation is not just better numbers, but more space for life itself.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
